Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
批准号:
10892444
负责人:
CHARLES ROBERTS
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-01 至 2024-02-29
关键词:
17 year oldAddressAdministrative SupplementAdultAwardCancer CenterCancer EtiologyCaregiversCaringCatchment AreaClinicCommunicationCommunitiesCommunity OutreachComprehensive Cancer CenterComputerized Medical RecordDataDisparityEducationEducation and OutreachEnsureFamilyGeneral PopulationGoalsHuman Papilloma Virus VaccinationHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusIntentionKnowledgeMeasuresMonitorOutcomeParentsPatient EducationPatientsPositioning AttributePrevention programPrintingSaint Jude Children&aposs Research HospitalSecond Primary CancersSurvivorsSystemTestingUnderserved PopulationVaccinatedVaccinationage groupcancer educationchildhood cancer survivorcollaborative approachcommunity engagementdesigneducation resourcesexperiencehealth literacyhuman old age (65+)improvedinnovationmobile applicationoncology programonline resourcepeerpilot testprocess evaluationsocial media
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Childhood cancer survivors are a high-priority, underserved population for HPV vaccination. They are less
likely to be vaccinated when compared to the general population and are more likely to develop second
cancers caused by HPV as adults. St. Jude Comprehensive Cancer Center (SJCCC) is uniquely positioned to
address observed disparities in HPV vaccination coverage among childhood cancer survivors by leveraging
our unique reach across our catchment area and building on award-winning, state-of-the-art communication
systems with those treated at SJCCC and their families. The overall goal of the proposed administrative
supplement is to improve HPV vaccination coverage among childhood cancer survivors. The specific aims are
to: (1) develop an innovative, culturally targeted, multi-channel educational campaign to enhance health
literacy related to HPV vaccination and to improve HPV vaccination coverage among childhood cancer
survivors; and (2) pilot test the multi-channel educational campaign to understand its impact on knowledge and
intention and to inform the next steps. Our proposed plan will build on established and newly developed patient
families and survivor-facing educational resources in English and Spanish, which are designed and
disseminated to promote and facilitate health literacy. Our approach will be highly iterative and include
engagement of key offices within St. Jude, including SJCCC Community Outreach and Engagement, HPV
Cancer Prevention Program, Strategic Communication, Education and Outreach, Patient Family Centered
Care, Patient Experience Office, Transition Oncology Program, After Completion of Therapy Clinic, and most
importantly, through our regular interaction with patient families and childhood cancer survivors through the
Patient Family Advisory Council and additional patient family advisors. The multi-channel campaign will focus
on web-based resources and communities, social media platforms, Our St. Jude mobile application (app),
traditional print formats, electronic medical record prompts for prescribed patient education, and peer-to-peer,
patient family champion experiences. We will target the 10-30-year-old age group with approaches
differentiated by 10-17-year-olds for whom parent/caregivers make vaccination decisions and 18-30-year olds
who can make vaccination decisions for themselves, in most instances. We will develop and pilot test an HPV
vaccination campaign across these multiple channels. Our project activities will be documented and monitored
through a comprehensive process evaluation. The preliminary impact of our efforts will also be measured using
qualitative, quantitative, and analytical data, including assessment of aggregated HPV vaccination rates before
and after the campaign implementation period. Our efforts will be aligned with St. Jude communication and
educational resources from the beginning to optimize sustainability. We will openly share our findings with
other cancer centers and organizations serving childhood cancer survivors and continue to refine and test our
approaches to ensure we are achieving impact through increased HPV vaccination coverage among childhood
cancer survivors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer-based discovery of novel mechanisms of chromatin control
-
批准号:10660680
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2023
-
负责人:CHARLES ROBERTS
-
依托单位:
Development and Piloting of a Stigma Assessment Tool for Global Pediatric Cancer
-
批准号:10844719
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2023
-
负责人:CHARLES ROBERTS
-
依托单位:
Enhancing Precision of Pediatric Cancer Molecular Targets by Aggregating CCDI Genomic Data to Pediatric Cancer Knowledgebase
-
批准号:10877602
-
项目类别:
-
资助金额:$49.92万
-
财政年份:2023
-
负责人:CHARLES ROBERTS
-
依托单位:
Role of the SWI/SNF complex in tumor suppression
-
批准号:10463748
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2013
-
负责人:CHARLES ROBERTS
-
依托单位:
Role of the SWI/SNF complex in tumor suppression
-
批准号:10248410
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2013
-
负责人:CHARLES ROBERTS
-
依托单位:
Analysis of the role of the SWI/SNF complex in tumor suppression
-
批准号:8689980
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2013
-
负责人:CHARLES ROBERTS
-
依托单位:
Analysis of the role of the SWI/SNF complex in tumor suppression
-
批准号:8579030
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2013
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:7086815
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:8676680
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:6906661
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:7993286
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:7468315
-
项目类别:
-
资助金额:$5.47万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:9161343
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor
-
批准号:10308725
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:8463468
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:8887594
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:7229611
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor
-
批准号:10540682
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:7623941
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
The function of Snf5, an epigenetic tumor suppressor
-
批准号:9045574
-
项目类别:
-
资助金额:$36.95万
-
财政年份:2005
-
负责人:CHARLES ROBERTS
-
依托单位:
海外基金